Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
21 February 2014 09:50
Clinical trials were carried out in vivo as well as in vitro
A new drug which selectively kills dormant cancer cells has been tested by scientists.
The molecule works by inducing dysfunction in mitochondria - the powerhouse of cells.
The research, conducted by Prof Stig Linder of the Swedish Karolinska Instituet and Uppsala University, found that a small molecule named VLX600 has been proven ineffective in killing dormant colon cancer cells in a variety of models, including in clinical trials and in test subjects with the medical condition.
Experts say that in solid tumours larger than a few millimetres, a lack of oxygen and nutrients is common as a result of insufficient growth in the blood vessels. This can cause cancer cells to remain dormant - and even after they receive treatment, they can divide, causing tumours to grow. This process helps cancers resist radiotherapy and chemotherapy.
The study shows that in these tumour areas that lack oxygen and nutrition, there is a lack of mitochondrial energy production for which the cancer cells cannot compensate. The researchers said: "Our ?ndings suggest that tumour cells in nutritionally compromised microenvironments are sensitive to disturbances of mitochondrial function, resulting in a bioenergetic catastrophe."
The VLX600 molecule was found to cause this dysfunction in mitochondria, causing colon cancer cells to die. When the substance was tested on colon cancer cell lines in vivo, it suppressed tumour growth. The molecule also helped boost other anti-cancer drugs, such as irinotecan.
The study leaders said: "Our ?ndings suggest that tumour cells in metabolically compromised microenvironments have a limited ability to respond to decreased mitochondrial function, and suggest a strategy for targeting the quiescent populations of tumour cells for improved cancer treatment."
People can find more information about travel insurance for cancer patients here.
12 October 2018
The rising cost of fuel could force more airlines out of business, the boss of easyJet has warned.
[more...]
11 October 2018
The image of the boozy backpacker might be a thing of the past as a new study suggests more and more youngsters are shunning alcohol completely.
10 October 2018
The NHS says just one in 10 drinks sold in English hospitals will be sugar-sweetened, as part of its bid to curb rising obesity levels.
09 October 2018
More than 260,000 diabetes patients were put at risk of lasting harm or even death during hospital stays last year due to medication errors, a new report has revealed.
06 October 2018
NHS patients with a specific type of lymphoma will soon be able to access a "game-changing" new treatment, health officials have revealed.
05 October 2018
People living with diabetes are being warned they might be "unwittingly" storing their insulin incorrectly.
04 October 2018
The world's first commercial jet part-powered by a new form of biofuel touches down in London on Wednesday (3rd October).
03 October 2018
New 'hotel-style' carriages that were due to be rolled out for the Caledonian Sleeper have been delayed until next year.
02 October 2018
Budapest has been revealed as the cheapest destination for UK holidaymakers looking for a cultural break, according to a new report.
29 September 2018
Holidaymakers heading off by train will soon be able to check their blood pressure at the station, as part of a new scheme aimed at boosting the number of people getting checked.
28 September 2018
Taking an aspirin every day might not only help keep cancer at bay, it could also play a life-saving role in treatment, new research suggests.
27 September 2018
Holidaymakers heading to Southern Europe for some autumn sun will be pleased to know that a Mediterranean diet could help prevent depression.